カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の承認済みCOVID-19ワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Approved COVID-19 Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19158）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19158
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の承認済みCOVID-19ワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

承認済みCOVID-19ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の承認済みCOVID-19ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

承認済みCOVID-19ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・コンポーネントウイルスワクチン、ホールウイルスワクチン

用途別セグメントは次のように区分されます。
・大人、子供、高齢者

世界の承認済みCOVID-19ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Moderna、CanSino Biologicals、Inovio Pharmaceuticals、Shenzhen Geno-Immune Medical Institute、GlaxoSmithKine、Pfizer、Johnson＆Johnson、Heat Biologics、Sanofi

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、承認済みCOVID-19ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な承認済みCOVID-19ワクチンメーカーの企業概要、2019年～2022年までの承認済みCOVID-19ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な承認済みCOVID-19ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別承認済みCOVID-19ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの承認済みCOVID-19ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での承認済みCOVID-19ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および承認済みCOVID-19ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、承認済みCOVID-19ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 承認済みCOVID-19ワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：コンポーネントウイルスワクチン、ホールウイルスワクチン
- 用途別分析（2017年vs2021年vs2028年）：大人、子供、高齢者
- 世界の承認済みCOVID-19ワクチン市場規模・予測
- 世界の承認済みCOVID-19ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Moderna、CanSino Biologicals、Inovio Pharmaceuticals、Shenzhen Geno-Immune Medical Institute、GlaxoSmithKine、Pfizer、Johnson＆Johnson、Heat Biologics、Sanofi
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：コンポーネントウイルスワクチン、ホールウイルスワクチン
・用途別分析2017年-2028年：大人、子供、高齢者
・承認済みCOVID-19ワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・承認済みCOVID-19ワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・承認済みCOVID-19ワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・承認済みCOVID-19ワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・承認済みCOVID-19ワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Approved COVID-19 Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Approved COVID-19 Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Adults accounting for % of the Approved COVID-19 Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Component Viral Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, and GlaxoSmithKine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Approved COVID-19 Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Component Viral Vaccines
Whole Virus Vaccines
Market segment by Application can be divided into
Adults
Children
Elderly
The key market players for global Approved COVID-19 Vaccines market are listed below:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Approved COVID-19 Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Approved COVID-19 Vaccines, with price, sales, revenue and global market share of Approved COVID-19 Vaccines from 2019 to 2022.
Chapter 3, the Approved COVID-19 Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Approved COVID-19 Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Approved COVID-19 Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Approved COVID-19 Vaccines.
Chapter 13, 14, and 15, to describe Approved COVID-19 Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Approved COVID-19 Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Approved COVID-19 Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Approved COVID-19 Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Market Size & Forecast
1.4.1 Global Approved COVID-19 Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Approved COVID-19 Vaccines Sales in Volume (2017-2028)
1.4.3 Global Approved COVID-19 Vaccines Price (2017-2028)
1.5 Global Approved COVID-19 Vaccines Production Capacity Analysis
1.5.1 Global Approved COVID-19 Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Approved COVID-19 Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Approved COVID-19 Vaccines Market Drivers
1.6.2 Approved COVID-19 Vaccines Market Restraints
1.6.3 Approved COVID-19 Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna Approved COVID-19 Vaccines Product and Services
2.1.4 Moderna Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CanSino Biologicals
2.2.1 CanSino Biologicals Details
2.2.2 CanSino Biologicals Major Business
2.2.3 CanSino Biologicals Approved COVID-19 Vaccines Product and Services
2.2.4 CanSino Biologicals Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Inovio Pharmaceuticals
2.3.1 Inovio Pharmaceuticals Details
2.3.2 Inovio Pharmaceuticals Major Business
2.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product and Services
2.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shenzhen Geno-Immune Medical Institute
2.4.1 Shenzhen Geno-Immune Medical Institute Details
2.4.2 Shenzhen Geno-Immune Medical Institute Major Business
2.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product and Services
2.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKine
2.5.1 GlaxoSmithKine Details
2.5.2 GlaxoSmithKine Major Business
2.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Product and Services
2.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Approved COVID-19 Vaccines Product and Services
2.6.4 Pfizer Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Johnson＆Johnson
2.7.1 Johnson＆Johnson Details
2.7.2 Johnson＆Johnson Major Business
2.7.3 Johnson＆Johnson Approved COVID-19 Vaccines Product and Services
2.7.4 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Heat Biologics
2.8.1 Heat Biologics Details
2.8.2 Heat Biologics Major Business
2.8.3 Heat Biologics Approved COVID-19 Vaccines Product and Services
2.8.4 Heat Biologics Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Approved COVID-19 Vaccines Product and Services
2.9.4 Sanofi Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Approved COVID-19 Vaccines Breakdown Data by Manufacturer
3.1 Global Approved COVID-19 Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Approved COVID-19 Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Approved COVID-19 Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Approved COVID-19 Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Approved COVID-19 Vaccines Manufacturer Market Share in 2021
3.5 Global Approved COVID-19 Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Approved COVID-19 Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Approved COVID-19 Vaccines Market Size by Region
4.1.1 Global Approved COVID-19 Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Approved COVID-19 Vaccines Revenue by Region (2017-2028)
4.2 North America Approved COVID-19 Vaccines Revenue (2017-2028)
4.3 Europe Approved COVID-19 Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Approved COVID-19 Vaccines Revenue (2017-2028)
4.5 South America Approved COVID-19 Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Approved COVID-19 Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Approved COVID-19 Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Approved COVID-19 Vaccines Revenue by Type (2017-2028)
5.3 Global Approved COVID-19 Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Approved COVID-19 Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Approved COVID-19 Vaccines Revenue by Application (2017-2028)
6.3 Global Approved COVID-19 Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Approved COVID-19 Vaccines Sales by Type (2017-2028)
7.2 North America Approved COVID-19 Vaccines Sales by Application (2017-2028)
7.3 North America Approved COVID-19 Vaccines Market Size by Country
7.3.1 North America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Approved COVID-19 Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Approved COVID-19 Vaccines Sales by Type (2017-2028)
8.2 Europe Approved COVID-19 Vaccines Sales by Application (2017-2028)
8.3 Europe Approved COVID-19 Vaccines Market Size by Country
8.3.1 Europe Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Approved COVID-19 Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Approved COVID-19 Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Approved COVID-19 Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Approved COVID-19 Vaccines Market Size by Region
9.3.1 Asia-Pacific Approved COVID-19 Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Approved COVID-19 Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Approved COVID-19 Vaccines Sales by Type (2017-2028)
10.2 South America Approved COVID-19 Vaccines Sales by Application (2017-2028)
10.3 South America Approved COVID-19 Vaccines Market Size by Country
10.3.1 South America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Approved COVID-19 Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Approved COVID-19 Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Approved COVID-19 Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Approved COVID-19 Vaccines Market Size by Country
11.3.1 Middle East & Africa Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Approved COVID-19 Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Approved COVID-19 Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Approved COVID-19 Vaccines
12.3 Approved COVID-19 Vaccines Production Process
12.4 Approved COVID-19 Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Approved COVID-19 Vaccines Typical Distributors
13.3 Approved COVID-19 Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Approved COVID-19 Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Approved COVID-19 Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Moderna Basic Information, Manufacturing Base and Competitors
Table 4. Moderna Major Business
Table 5. Moderna Approved COVID-19 Vaccines Product and Services
Table 6. Moderna Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CanSino Biologicals Basic Information, Manufacturing Base and Competitors
Table 8. CanSino Biologicals Major Business
Table 9. CanSino Biologicals Approved COVID-19 Vaccines Product and Services
Table 10. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Inovio Pharmaceuticals Major Business
Table 13. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product and Services
Table 14. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shenzhen Geno-Immune Medical Institute Basic Information, Manufacturing Base and Competitors
Table 16. Shenzhen Geno-Immune Medical Institute Major Business
Table 17. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product and Services
Table 18. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKine Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKine Major Business
Table 21. GlaxoSmithKine Approved COVID-19 Vaccines Product and Services
Table 22. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Approved COVID-19 Vaccines Product and Services
Table 26. Pfizer Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Johnson＆Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson＆Johnson Major Business
Table 29. Johnson＆Johnson Approved COVID-19 Vaccines Product and Services
Table 30. Johnson＆Johnson Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Heat Biologics Basic Information, Manufacturing Base and Competitors
Table 32. Heat Biologics Major Business
Table 33. Heat Biologics Approved COVID-19 Vaccines Product and Services
Table 34. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Approved COVID-19 Vaccines Product and Services
Table 38. Sanofi Approved COVID-19 Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Approved COVID-19 Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Approved COVID-19 Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Approved COVID-19 Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Approved COVID-19 Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Approved COVID-19 Vaccines Production Site of Key Manufacturer
Table 44. Approved COVID-19 Vaccines New Entrant and Capacity Expansion Plans
Table 45. Approved COVID-19 Vaccines Mergers & Acquisitions in the Past Five Years
Table 46. Global Approved COVID-19 Vaccines Sales by Region (2017-2022) & (K Units)
Table 47. Global Approved COVID-19 Vaccines Sales by Region (2023-2028) & (K Units)
Table 48. Global Approved COVID-19 Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Approved COVID-19 Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)
Table 51. Global Approved COVID-19 Vaccines Sales by Type (2023-2028) & (K Units)
Table 52. Global Approved COVID-19 Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Approved COVID-19 Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Approved COVID-19 Vaccines Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Approved COVID-19 Vaccines Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. Global Approved COVID-19 Vaccines Sales by Application (2023-2028) & (K Units)
Table 58. Global Approved COVID-19 Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Approved COVID-19 Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Approved COVID-19 Vaccines Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Approved COVID-19 Vaccines Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. North America Approved COVID-19 Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. North America Approved COVID-19 Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Approved COVID-19 Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)
Table 67. North America Approved COVID-19 Vaccines Sales by Type (2023-2028) & (K Units)
Table 68. North America Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. North America Approved COVID-19 Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. Europe Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)
Table 71. Europe Approved COVID-19 Vaccines Sales by Country (2023-2028) & (K Units)
Table 72. Europe Approved COVID-19 Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Approved COVID-19 Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. Europe Approved COVID-19 Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. Europe Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)
Table 77. Europe Approved COVID-19 Vaccines Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Approved COVID-19 Vaccines Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Approved COVID-19 Vaccines Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Approved COVID-19 Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Approved COVID-19 Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Approved COVID-19 Vaccines Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Approved COVID-19 Vaccines Sales by Application (2023-2028) & (K Units)
Table 86. South America Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)
Table 87. South America Approved COVID-19 Vaccines Sales by Country (2023-2028) & (K Units)
Table 88. South America Approved COVID-19 Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Approved COVID-19 Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)
Table 91. South America Approved COVID-19 Vaccines Sales by Type (2023-2028) & (K Units)
Table 92. South America Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)
Table 93. South America Approved COVID-19 Vaccines Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Approved COVID-19 Vaccines Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Approved COVID-19 Vaccines Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Approved COVID-19 Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Approved COVID-19 Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Approved COVID-19 Vaccines Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Approved COVID-19 Vaccines Sales by Application (2023-2028) & (K Units)
Table 102. Approved COVID-19 Vaccines Raw Material
Table 103. Key Manufacturers of Approved COVID-19 Vaccines Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Approved COVID-19 Vaccines Typical Distributors
Table 107. Approved COVID-19 Vaccines Typical Customers
List of Figures
Figure 1. Approved COVID-19 Vaccines Picture
Figure 2. Global Approved COVID-19 Vaccines Revenue Market Share by Type in 2021
Figure 3. Component Viral Vaccines
Figure 4. Whole Virus Vaccines
Figure 5. Global Approved COVID-19 Vaccines Revenue Market Share by Application in 2021
Figure 6. Adults
Figure 7. Children
Figure 8. Elderly
Figure 9. Global Approved COVID-19 Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Approved COVID-19 Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Approved COVID-19 Vaccines Sales (2017-2028) & (K Units)
Figure 12. Global Approved COVID-19 Vaccines Price (2017-2028) & (US$/Unit)
Figure 13. Global Approved COVID-19 Vaccines Production Capacity (2017-2028) & (K Units)
Figure 14. Global Approved COVID-19 Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Approved COVID-19 Vaccines Market Drivers
Figure 16. Approved COVID-19 Vaccines Market Restraints
Figure 17. Approved COVID-19 Vaccines Market Trends
Figure 18. Global Approved COVID-19 Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global Approved COVID-19 Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Approved COVID-19 Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Approved COVID-19 Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Approved COVID-19 Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America Approved COVID-19 Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe Approved COVID-19 Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Approved COVID-19 Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America Approved COVID-19 Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Approved COVID-19 Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Approved COVID-19 Vaccines Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global Approved COVID-19 Vaccines Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Approved COVID-19 Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America Approved COVID-19 Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America Approved COVID-19 Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Approved COVID-19 Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe Approved COVID-19 Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Approved COVID-19 Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Approved COVID-19 Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Approved COVID-19 Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America Approved COVID-19 Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America Approved COVID-19 Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Approved COVID-19 Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Approved COVID-19 Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Approved COVID-19 Vaccines in 2021
Figure 77. Manufacturing Process Analysis of Approved COVID-19 Vaccines
Figure 78. Approved COVID-19 Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の新型コロナウイルス感染症用経口抗ウイルス薬市場2022年：市場規模予測（～2028年）
  • 世界の新型コロナウイルス感染症用RT-PCR検出キット市場2022年：市場規模予測（～2028年）
  • 世界の新型コロナウイルス感染症用迅速抗体検査キット市場2022年：市場規模予測（～2028年）
  • 世界の新興がんワクチン市場2022年：市場規模予測（～2028年）
  • 世界の新型コロナウイルス感染症用鼻スワブ検査市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19158 )"世界の承認済みCOVID-19ワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Approved COVID-19 Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。